Literature DB >> 22751440

Chenodeoxycholic acid through a TGR5-dependent CREB signaling activation enhances cyclin D1 expression and promotes human endometrial cancer cell proliferation.

Ivan Casaburi1, Paola Avena, Marilena Lanzino, Diego Sisci, Francesca Giordano, Pamela Maris, Stefania Catalano, Catia Morelli, Sebastiano Andò.   

Abstract

Endometrial cancer exhibits a strong incidence in western developed countries mainly due to fat-rich diet and obesity. Processing of dietary lipids is triggered by bile acids, amphipathic detergents that are synthesized in the liver and stored in the gallbladder. In addition to their well-recognized role in dietary lipid absorption and cholesterol homeostasis, bile acids can also act as signaling molecules with systemic endocrine functions. In the present study we investigated the biological effects of the primary bile chenodeoxycholic acid (CDCA) on a human endometrial cancer cell line, Ishikawa. Low concentrations of CDCA are able to stimulate Ishikawa cell growth by inducing a significant increase in Cyclin D1 protein and mRNA expression through the activation of the membrane G protein-coupled receptor (TGR5)-dependent pathway. Dissecting the molecular mechanism underlying this effect by mutagenesis, EMSA and ChIP analysis revealed that CDCA-induced Cyclin D1 expression requires the enhanced recruitment of the transcription factor CREB on the cyclic AMP-responsive element motif within the Cyclin D1 gene proximal promoter. Our results suggest a novel molecular mechanism explaining the potential contribution of high-fat diet and obesity to endometrial cancer growth and progression opening the rationale for strategies to prevent the risk of this obesity-related cancer in women.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22751440     DOI: 10.4161/cc.21029

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  22 in total

1.  Extracellular HSP70-peptide complexes promote the proliferation of hepatocellular carcinoma cells via TLR2/4/JNK1/2MAPK pathway.

Authors:  Yi Zhe; Yan Li; Dan Liu; Dong-Ming Su; Jin-Gang Liu; Hang-Yu Li
Journal:  Tumour Biol       Date:  2016-08-04

Review 2.  Bile acid dysregulation, gut dysbiosis, and gastrointestinal cancer.

Authors:  Jessica Tsuei; Thinh Chau; David Mills; Yu-Jui Yvonne Wan
Journal:  Exp Biol Med (Maywood)       Date:  2014-06-20

3.  TGR5 contributes to hepatic cystogenesis in rodents with polycystic liver diseases through cyclic adenosine monophosphate/Gαs signaling.

Authors:  Tatyana V Masyuk; Anatoliy I Masyuk; Maria Lorenzo Pisarello; Brynn N Howard; Bing Q Huang; Pui-Yuen Lee; Xavier Fung; Eduard Sergienko; Robert J Ardecky; Thomas D Y Chung; Anthony B Pinkerton; Nicholas F LaRusso
Journal:  Hepatology       Date:  2017-08-26       Impact factor: 17.425

4.  Structural basis and molecular mechanism of biased GPBAR signaling in regulating NSCLC cell growth via YAP activity.

Authors:  Lijuan Ma; Fan Yang; Xiang Wu; Chunyou Mao; Lulu Guo; Tianshu Miao; Shao-Kun Zang; Xiaoyu Jiang; Dan-Dan Shen; Tianhui Wei; Hengxing Zhou; Qin Wei; Shiyang Li; Qiang Shu; Shiqing Feng; Changtao Jiang; Bo Chu; Lutao Du; Jin-Peng Sun; Xiao Yu; Yan Zhang; Pengju Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2022-07-15       Impact factor: 12.779

Review 5.  Deregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer: possibilities for therapeutic intervention.

Authors:  Nicole M Davis; Melissa Sokolosky; Kristin Stadelman; Steve L Abrams; Massimo Libra; Saverio Candido; Ferdinando Nicoletti; Jerry Polesel; Roberta Maestro; Antonino D'Assoro; Lyudmyla Drobot; Dariusz Rakus; Agnieszka Gizak; Piotr Laidler; Joanna Dulińska-Litewka; Joerg Basecke; Sanja Mijatovic; Danijela Maksimovic-Ivanic; Giuseppe Montalto; Melchiorre Cervello; Timothy L Fitzgerald; Zoya Demidenko; Alberto M Martelli; Lucio Cocco; Linda S Steelman; James A McCubrey
Journal:  Oncotarget       Date:  2014-07-15

6.  Taurolithocholic acid promotes intrahepatic cholangiocarcinoma cell growth via muscarinic acetylcholine receptor and EGFR/ERK1/2 signaling pathway.

Authors:  Sumet Amonyingcharoen; Tawit Suriyo; Apinya Thiantanawat; Piyajit Watcharasit; Jutamaad Satayavivad
Journal:  Int J Oncol       Date:  2015-03-27       Impact factor: 5.650

7.  Inhibition of RUNX2 transcriptional activity blocks the proliferation, migration and invasion of epithelial ovarian carcinoma cells.

Authors:  Zhi-Qiang Wang; Mamadou Keita; Magdalena Bachvarova; Stephane Gobeil; Chantale Morin; Marie Plante; Jean Gregoire; Marie-Claude Renaud; Alexandra Sebastianelli; Xuan Bich Trinh; Dimcho Bachvarov
Journal:  PLoS One       Date:  2013-10-04       Impact factor: 3.240

8.  DAX-1, as an androgen-target gene, inhibits aromatase expression: a novel mechanism blocking estrogen-dependent breast cancer cell proliferation.

Authors:  M Lanzino; P Maris; R Sirianni; I Barone; I Casaburi; A Chimento; C Giordano; C Morelli; D Sisci; P Rizza; D Bonofiglio; S Catalano; S Andò
Journal:  Cell Death Dis       Date:  2013-07-11       Impact factor: 8.469

9.  Membrane bile acid receptor TGR5 predicts good prognosis in ampullary adenocarcinoma patients with hyperbilirubinemia.

Authors:  Min-Chan Chen; Yi-Ling Chen; Tzu-Wen Wang; Hui-Ping Hsu; Ming-Derg Lai
Journal:  Oncol Rep       Date:  2016-08-10       Impact factor: 3.906

10.  Role of Scaffold Protein Proline-, Glutamic Acid-, and Leucine-Rich Protein 1 (PELP1) in the Modulation of Adrenocortical Cancer Cell Growth.

Authors:  Arianna De Luca; Paola Avena; Rosa Sirianni; Adele Chimento; Francesco Fallo; Catia Pilon; Ivan Casaburi; Vincenzo Pezzi
Journal:  Cells       Date:  2017-11-07       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.